Trial Outcomes & Findings for Wide Diameter Bone Anchored Implant Study (NCT NCT01671176)

NCT ID: NCT01671176

Last Updated: 2018-05-07

Results Overview

Holger's Scale is a 5 point that ranges from 0 - 4 scale that assesses skin reactions at the implant site where 0 means no reaction and 4 means excessive granulation, skin overgrowth, or scar formation requiring revision surgery

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

1 week, 3 weeks, 6 weeks, 3 months, 6 months and 12 months

Results posted on

2018-05-07

Participant Flow

Participant milestones

Participant milestones
Measure
Wide Diameter Bone Anchored Implant
Intervention: Implantation of a wide diameter bone anchored auditory implant either 3 or 4 mm in length, into the skull on the side of the ear where intervention is intended in order to restore hearing. In the case of a conductive or mixed hearing loss, that side is chosen. In patients with unilateral, profound sensori-neural hearing loss the implant is implanted on that side but the sound is transmitted to the side with the normal hearing ear via bone conduction stimulation. Wide diameter bone anchored implant: 4.5 mm wide diameter bone anchored implant
Overall Study
STARTED
30
Overall Study
COMPLETED
30
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Wide Diameter Bone Anchored Implant Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Wide Diameter Bone Anchored Implant
n=30 Participants
Intervention: Implantation of a wide diameter bone anchored auditory implant either 3 or 4 mm in length, into the skull on the side of the ear where intervention is intended in order to restore hearing. In the case of a conductive or mixed hearing loss, that side is chosen. In patients with unilateral, profound sensori-neural hearing loss the implant is implanted on that side but the sound is transmitted to the side with the normal hearing ear via bone conduction stimulation. Wide diameter bone anchored implant: 4.5 mm wide diameter bone anchored implant
Age, Continuous
60.83 years
STANDARD_DEVIATION 16.07 • n=5 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
Sex: Female, Male
Male
8 Participants
n=5 Participants
Region of Enrollment
United States
30 participants
n=5 Participants
Smoking status
yes
1 participants
n=5 Participants
Smoking status
no
29 participants
n=5 Participants
Diabetes
yes
3 participants
n=5 Participants
Diabetes
no
27 participants
n=5 Participants
Abutment length
6 mm
20 participants
n=5 Participants
Abutment length
9 mm
7 participants
n=5 Participants
Abutment length
12 mm
3 participants
n=5 Participants
Weight
76.72 kilogram
STANDARD_DEVIATION 19.61 • n=5 Participants
BMI
28.56 kilogram/M^2
STANDARD_DEVIATION 7.09 • n=5 Participants
Height
163.79 centimeters
STANDARD_DEVIATION 8.89 • n=5 Participants

PRIMARY outcome

Timeframe: 1 week, 3 weeks, 6 weeks, 3 months, 6 months and 12 months

Holger's Scale is a 5 point that ranges from 0 - 4 scale that assesses skin reactions at the implant site where 0 means no reaction and 4 means excessive granulation, skin overgrowth, or scar formation requiring revision surgery

Outcome measures

Outcome measures
Measure
Wide Diameter Bone Anchored Implant
n=30 Participants
Intervention: Implantation of a wide diameter bone anchored auditory implant either 3 or 4 mm in length, into the skull on the side of the ear where intervention is intended in order to restore hearing. In the case of a conductive or mixed hearing loss, that side is chosen. In patients with unilateral, profound sensori-neural hearing loss the implant is implanted on that side but the sound is transmitted to the side with the normal hearing ear via bone conduction stimulation. Wide diameter bone anchored implant: 4.5 mm wide diameter bone anchored implant
Holger's Scale
Holger score of 1 at 3 months
1 participants
Holger's Scale
Holger score of 2 at 3 months
0 participants
Holger's Scale
Holger score of 0 at 6 months
30 participants
Holger's Scale
Holger score 0 at 1 week
29 participants
Holger's Scale
Holger score of 1 at one week
0 participants
Holger's Scale
Holger score of 2 at one week
1 participants
Holger's Scale
Holger score of 0 at 3 weeks
29 participants
Holger's Scale
Holger score of 1 at 3 weeks
1 participants
Holger's Scale
Holger score of 2 at 3 weeks
0 participants
Holger's Scale
Holger score of 0 at 6 weeks
28 participants
Holger's Scale
Holger score of 1 at 6 weeks
2 participants
Holger's Scale
Holger score of 2 at 6 weeks
0 participants
Holger's Scale
Holger score of 0 at 3 months
29 participants
Holger's Scale
Holger score of 1 at 6 months
0 participants
Holger's Scale
Holger score of 2 at 6 months
0 participants
Holger's Scale
Holger score of 0 at 12 months
29 participants
Holger's Scale
olger score of 1 at 12 months 1
1 participants
Holger's Scale
Holger score of 2 at 12 months
0 participants

PRIMARY outcome

Timeframe: At surgery, 1 week, 3 weeks, 6 weeks, 12 weeks, 6 months and 12 months

Presently, the recommendations to load the sound processor on a bone anchored implant is 3 months (for adults). Using outcome measures, i.e., OSSTELL ISQ ranges from 0 -100 where 0 is least stable and 100 being the most stable.

Outcome measures

Outcome measures
Measure
Wide Diameter Bone Anchored Implant
n=30 Participants
Intervention: Implantation of a wide diameter bone anchored auditory implant either 3 or 4 mm in length, into the skull on the side of the ear where intervention is intended in order to restore hearing. In the case of a conductive or mixed hearing loss, that side is chosen. In patients with unilateral, profound sensori-neural hearing loss the implant is implanted on that side but the sound is transmitted to the side with the normal hearing ear via bone conduction stimulation. Wide diameter bone anchored implant: 4.5 mm wide diameter bone anchored implant
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ horizontal at one week
59.77 units on a scale
Standard Deviation 7.88
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ vertical at 12 weeks
61.97 units on a scale
Standard Deviation 5.91
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ vertical at 6 month
63.62 units on a scale
Standard Deviation 5.26
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ horizontal at 6 months
63.27 units on a scale
Standard Deviation 5.48
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ vertical at 12 months
63.73 units on a scale
Standard Deviation 5.31
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ vertical at surgery
58.43 units on a scale
Standard Deviation 8.01
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ horizontal at surgery
58.58 units on a scale
Standard Deviation 7.42
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ vertical at one week
59.70 units on a scale
Standard Deviation 7.03
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ vertical at 3 weeks
60.53 units on a scale
Standard Deviation 7.14
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ horizontal at 3 weeks
60.30 units on a scale
Standard Deviation 7.78
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ vertical at 6 weeks
61.28 units on a scale
Standard Deviation 5.81
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ horizontal at 6 weeks
61.02 units on a scale
Standard Deviation 6.56
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ horizontal at 12 weeks
62.00 units on a scale
Standard Deviation 6.07
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane
ISQ horizontal at 12 months
63.62 units on a scale
Standard Deviation 5.26

Adverse Events

Wide Diameter Bone Anchored Implant

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Wide Diameter Bone Anchored Implant
n=30 participants at risk
Intervention: Implantation of a wide diameter bone anchored auditory implant either 3 or 4 mm in length, into the skull on the side of the ear where intervention is intended in order to restore hearing. In the case of a conductive or mixed hearing loss, that side is chosen. In patients with unilateral, profound sensori-neural hearing loss the implant is implanted on that side but the sound is transmitted to the side with the normal hearing ear via bone conduction stimulation. Wide diameter bone anchored implant: 4.5 mm wide diameter bone anchored implant
Skin and subcutaneous tissue disorders
Skin revision
3.3%
1/30

Other adverse events

Adverse event data not reported

Additional Information

Ravi Sockalingam

Oticon Medical LLC

Phone: 9082023524

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place